Poster 47
- May 19, 2023
- 1 min read
Avapritinib Achieves Durable Improvement in Skin Findings With a Well-Tolerated Safety Profile in Patients With Indolent Systemic Mastocytosis (ISM): Long-term Analyses From the PIONEER Study
Karin Hartmann, Cem Akin, Frank Siebenhaar, Sigurd Broesby-Olsen, Hanneke Oude Elberink, Tracy I. George, Hui-Min Lin, Ilda Bidollari, Kate Newberry, Ashley Doyle, Lauren Madigan


